Pilar Banos-Alvarez
Burgos, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
Journal: The lancet. Diabetes & endocrinology
Published: May 22, 2024
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study.
Journal: Circulation. Cardiovascular imaging
Published: January 11, 2024
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study.
Journal: European journal of preventive cardiology
Published: August 24, 2022
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients.
Journal: Journal of clinical lipidology
Published: April 06, 2022
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
Journal: Current atherosclerosis reports
Published: March 09, 2022
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience.
Journal: Journal of clinical lipidology
Published: February 25, 2021
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
Journal: Journal of clinical lipidology
Published: July 11, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026